AngioDynamics Debt Non Current from 2010 to 2023

ANGO Stock  USD 12.42  0.37  3.07%   
AngioDynamics Debt Non Current yearly trend continues to be very stable with very little volatility. Debt Non Current is likely to grow to about 23.1 M this year. During the period from 2010 to 2023, AngioDynamics Debt Non Current quarterly data regression pattern had range of 122,500,000 and median of  104,291,000. AngioDynamics Interest Expense is very stable at the moment as compared to the past year. AngioDynamics reported last year Interest Expense of 619,200. As of 27th of March 2023, Operating Expenses is likely to grow to about 224.5 M, while Direct Expenses is likely to drop about 130.8 M.
  
Check AngioDynamics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among AngioDynamics main balance sheet or income statement drivers, such as Direct Expenses of 130.8 M, Cost of Revenue of 131.1 M or Gross Profit of 145.1 M, as well as many exotic indicators such as Interest Coverage of 2.76, Long Term Debt to Equity of 0.0695 or PPandE Turnover of 6.82. AngioDynamics financial statements analysis is a perfect complement when working with AngioDynamics Valuation or Volatility modules. It can also supplement AngioDynamics' financial leverage analysis and stock options assessment as well as various AngioDynamics Technical models . Check out the analysis of AngioDynamics Correlation against competitors. To learn how to invest in AngioDynamics Stock please use our How to Invest in AngioDynamics guide.

AngioDynamics Quarterly Debt Non Current

49.8 Million

AngioDynamics Debt Non Current Breakdown

Showing smoothed Debt Non Current of AngioDynamics with missing and latest data points interpolated. The non-current portion of Total Debt reported if the company operates a classified balance sheet that segments current and non-current liabilities. Where this item is not contained on the company consolidated financial statements the default value on 0 is used.AngioDynamics' Debt Non Current historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in AngioDynamics' overall financial position and show how it may be relating to other accounts over time.
Debt Non Current10 Years Trend
Down
Slightly volatile
   Debt Non Current   
       Timeline  

AngioDynamics Debt Non Current Regression Statistics

Arithmetic Mean87,414,365
Geometric Mean68,673,117
Coefficient Of Variation57.89
Mean Deviation43,896,155
Median104,291,000
Standard Deviation50,602,917
Range122,500,000
R-Value(0.92)
R-Squared0.85
Significance0.00000273
Slope(11,153,459)

AngioDynamics Debt Non Current History

202323.1 M
202222.5 M
202125 M
202020 M
201940 M
2018124.4 M
201786.6 M
201691.3 M
2015104.3 M
2014128.9 M
2013137.7 M

About AngioDynamics Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include AngioDynamics income statement, its balance sheet, and the statement of cash flows. AngioDynamics investors use historical funamental indicators, such as AngioDynamics's Debt Non Current, to determine how well the company is positioned to perform in the future. Although AngioDynamics investors may use each financial statement separately, they are all related. The changes in AngioDynamics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on AngioDynamics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on AngioDynamics Financial Statements. Understanding these patterns can help to make the right decision on long term investment in AngioDynamics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2023
Debt Non Current22.5 M23.1 M

Be your own money manager

Our tools can tell you how much better you can do entering a position in AngioDynamics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Idea Breakdown Now

   

Idea Breakdown

Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
All  Next Launch Module

Pair Trading with AngioDynamics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if AngioDynamics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AngioDynamics will appreciate offsetting losses from the drop in the long position's value.

Moving together with AngioDynamics

+0.78ABTAbbott Laboratories Fiscal Quarter End 31st of March 2023 PairCorr
+0.74ALHCAlignment Healthcare LLC Fiscal Quarter End 31st of March 2023 PairCorr

Moving against AngioDynamics

-0.69ACCDAccoladeInc Report 27th of April 2023 PairCorr
-0.69ATECAlphatec Holdings Fiscal Quarter End 31st of March 2023 PairCorr
-0.61AMEHApollo Medical Holdings Fiscal Quarter End 31st of March 2023 PairCorr
-0.42CPSIComputer Programs And Fiscal Quarter End 31st of March 2023 PairCorr
The ability to find closely correlated positions to AngioDynamics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace AngioDynamics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back AngioDynamics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling AngioDynamics to buy it.
The correlation of AngioDynamics is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as AngioDynamics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if AngioDynamics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for AngioDynamics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out the analysis of AngioDynamics Correlation against competitors. To learn how to invest in AngioDynamics Stock please use our How to Invest in AngioDynamics guide. Note that the AngioDynamics information on this page should be used as a complementary analysis to other AngioDynamics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Complementary Tools for AngioDynamics Stock analysis

When running AngioDynamics price analysis, check to measure AngioDynamics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AngioDynamics is operating at the current time. Most of AngioDynamics' value examination focuses on studying past and present price action to predict the probability of AngioDynamics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move AngioDynamics' price. Additionally, you may evaluate how the addition of AngioDynamics to your portfolios can decrease your overall portfolio volatility.
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Equity Valuation
Check real value of public entities based on technical and fundamental data
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Is AngioDynamics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AngioDynamics. If investors know AngioDynamics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AngioDynamics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.83) 
Revenue Per Share
8.353
Quarterly Revenue Growth
0.091
Return On Assets
(0.0247) 
Return On Equity
(0.08) 
The market value of AngioDynamics is measured differently than its book value, which is the value of AngioDynamics that is recorded on the company's balance sheet. Investors also form their own opinion of AngioDynamics' value that differs from its market value or its book value, called intrinsic value, which is AngioDynamics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AngioDynamics' market value can be influenced by many factors that don't directly affect AngioDynamics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AngioDynamics' value and its price as these two are different measures arrived at by different means. Investors typically determine AngioDynamics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AngioDynamics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.